Bone mineralization flaws and you can vitamin D lack: histomorphometric data out of iliac crest bone biopsies and releasing twenty five-hydroxyvitamin D into the 675 clients. J Bone Miner Res 2010; 25: 305–312.
Zhou Y, sailor dating apps Zhao LJ, Xu X mais aussi al. DNA methylation levels of CYP2R1 and you will CYP24A1 anticipate supplement D response type. J Steroid Biochem Mol Biol 2014; 144: 207–214.
Ralston SH, Binkley Letter, Boonen S et al. Randomized trial off alendronate and additionally vitamin D3 in the place of simple care when you look at the osteoporotic postmenopausal girls having supplement D insufficiency. Calcif Structure Int 2011; 88: 485–494.
Weber K, Kaschig C, Erben RG . step one Leader-hydroxyvitamin D2 and you may 1 leader-hydroxyvitamin D3 have anabolic outcomes for the cortical bones, but trigger intracortical building work in the toxic doses during the ovariectomized rats. Limbs 2004; 35: 704–710.
Li Yards, Healy DR, Simmons HA ainsi que al. Alfacalcidol regulates cancellous bone inside ovariectomized rats. J Musculoskelet Neuronal Collaborate 2003; 3: 39–46.
Treatment that have elage, and collagen crosslinks during the primate bone
Orimo H, Shiraki Yards, Hayashi Y et al. Ramifications of step one leader-hydroxyvitamin D3 into the lumbar bone nutrient thickness and you will spinal cracks into the patients that have postmenopausal osteoporosis. Calcif Tissues Int 1994; 54: 370–376.
Shikari Kushida Meters, Yamazaki K, Nagai K ainsi que al. H. Outcomes of 2 years’ treatment of weakening of bones having step 1 alpha-hydroxy supplement D3 to the bones nutrient thickness and chance away from break: a placebo-managed, double-blind prospective analysis. Endocr J 1996; 43: 211–220.
Nuti Roentgen, Bianchi G, Brandi ML et al. Quality away from alfacalcidol versus supplement D plus calcium inside lumbar bone mineral occurrence when you look at the postmenopausal weakening of bones. Rheumatol Int 2006; 26: 445–453.
Kubodera Letter, Tsuji Letter, Uchiyama Y mais aussi al. Yet another active supplement D analogue, ED-71, factors boost in bone mass that have preferential effects into the bones into the osteoporotic people. J Cell Biochem 2003; 88: 286–289.
Abe Yards, Tsuji N, Takahashi F mais aussi al. Post on new systematic pharmacokinetics out of elin D3 by-product. Jpn Pharmacol Ther 2011; 39: 261–274.
Ritter CS, Brown AJ . Suppression off PTH by supplement D analogue eldecalcitol was modulated by their high affinity to the solution vitamin D-joining necessary protein and you may effectiveness metabolic process. J Cellphone Biochem 2011; 112: 1348–1352.
Kondo S, Takano T, Ono Y ainsi que al. Eldecalcitol reduces osteoporotic cracks by novel systems. J Steroid Biochem Mol Biol 2015; 148: 232–238.
Harada S, Mizoguchi T, Kobayashi Y ainsi que al. Day-after-day management from elin D analogue, expands limbs mineral occurrence from the suppressing RANKL term within the mouse trabecular bone. J Bone Miner Res 2012; 27: 461–473.
Hayashi Y, Fujita T, Inoue T
Matsumoto T, Ito Yards, Hayashi Y ainsi que al. Another productive vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures–a great randomized, effective comparator, double-blind investigation. Bone 2011; 49: 605–612.
Matsumoto T, Takano T, Saito H ainsi que al. Supplement D analogs and you can bones: preclinical and you may clinical studies with este; 3: 513.
Sakai A good, Ito Meters, Tomomitsu T et al. Efficacy from shared therapy which have alendronate (ALN) and elin D analogue, compared to that out-of concomitant ALN, vitamin D also calcium treatment when you look at the Japanese customers that have pri; 26: 1193–1202.
Plum La, Fitzpatrick Los angeles, Ma X ainsi que al. 2MD, a different anabolic broker to own osteoporosis therapy. Osteoporos Int 2006; 17: 704–715.
Ke HZ, Qi H, Crawford DT mais aussi al. Another type of supplement D analog, 2MD, restores trabecular and you may cortical bones size and you may fuel during the ovariectomized mice having centered osteopenia. J Limbs Miner Res 2005; 20: 1742–1755.
DeLuca HF, Bedale W, Binkley Letter mais aussi al. The newest vitamin D analog 2MD grows bones turnover but not BMD into the postmenopausal women which have osteopenia: results of a 1-year phase 2 twice-blind, placebo-regulated, randomized clinical test. J Limbs Miner Res 2011; 26: 538–545.